IDEAL DIABETES CIC

Company limited by guarantee

Company Registration Number:
12709586 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2023

Period of accounts

Start date: 1 August 2022

End date: 31 July 2023

IDEAL DIABETES CIC

Contents of the Financial Statements

for the Period Ended 31 July 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

IDEAL DIABETES CIC

Directors' report period ended 31 July 2023

The directors present their report with the financial statements of the company for the period ended 31 July 2023

Principal activities of the company

The company's principal activity during the period was to improve care pathways for people withdiabetes.



Directors

The directors shown below have held office during the whole of the period from
1 August 2022 to 31 July 2023

John Grumitt
Anne Phillips


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
1 March 2024

And signed on behalf of the board by:
Name: John Grumitt
Status: Director

IDEAL DIABETES CIC

Profit And Loss Account

for the Period Ended 31 July 2023

2023 2022


£

£
Turnover: 56,485 53,001
Gross profit(or loss): 56,485 53,001
Administrative expenses: ( 56,334 ) ( 52,097 )
Operating profit(or loss): 151 904
Profit(or loss) before tax: 151 904
Tax: ( 29 ) ( 172 )
Profit(or loss) for the financial year: 122 732

IDEAL DIABETES CIC

Balance sheet

As at 31 July 2023

Notes 2023 2022


£

£
Current assets
Cash at bank and in hand: 29,562 2,873
Total current assets: 29,562 2,873
Creditors: amounts falling due within one year: 3 ( 27,159 ) ( 592 )
Net current assets (liabilities): 2,403 2,281
Total assets less current liabilities: 2,403 2,281
Total net assets (liabilities): 2,403 2,281
Members' funds
Profit and loss account: 2,403 2,281
Total members' funds: 2,403 2,281

The notes form part of these financial statements

IDEAL DIABETES CIC

Balance sheet statements

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 March 2024
and signed on behalf of the board by:

Name: John Grumitt
Status: Director

The notes form part of these financial statements

IDEAL DIABETES CIC

Notes to the Financial Statements

for the Period Ended 31 July 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discountsand value added taxes. Turnover includes revenue earned from the sale of goods and from therendering of services. Turnover from the sale of goods is recognised when the significant risks andrewards of ownership of the goods have transferred to the buyer. Turnover from the rendering ofservices is recognised by reference to the stage of completion of the contract. The stage ofcompletion of a contract is measured by comparing the costs incurred for work performed to dateto the total estimated contract costs.

    Other accounting policies

    DebtorsShort term debtors are measured at transaction price (which is usually the invoice price), less anyimpairment losses for bad and doubtful debts. Loans and other financial assets are initiallyrecognised at transaction price including any transaction costs and subsequently measured atamortised cost determined using the effective interest method, less any impairment losses for badand doubtful debts.CreditorsShort term creditors are measured at transaction price (which is usually the invoice price). Loansand other financial liabilities are initially recognised at transaction price net of any transaction costsand subsequently measured at amortised cost determined using the effective interest method.ProvisionsProvisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation atthe reporting date as a result of a past event, it is probable that economic benefit will be transferredto settle the obligation and the amount of the obligation can be estimated reliably.

IDEAL DIABETES CIC

Notes to the Financial Statements

for the Period Ended 31 July 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 0 0

IDEAL DIABETES CIC

Notes to the Financial Statements

for the Period Ended 31 July 2023

3. Creditors: amounts falling due within one year note

2023 2022
£ £
Trade creditors 500 0
Taxation and social security 29 172
Other creditors 26,630 420
Total 27,159 592

COMMUNITY INTEREST ANNUAL REPORT

IDEAL DIABETES CIC

Company Number: 12709586 (England and Wales)

Year Ending: 31 July 2023

Company activities and impact

iDEAL Diabetes CIC enables the delivery of best practice in diabetes care for every person living with diabetes. Having identified gaps in care and support provided to people living with and at risk of diabetes, it provides practical tools and position papers on key topics around diabetes care to health care professionals, people with diabetes and the community.During the financial year ending 31st June 2023 the activities carried out by iDEAL have benefitted health care professionals, people with diabetes and the community in the following ways:Across the UK and globally, healthcare professionals and people with diabetes have had access to a simple and effective system to identify early warning signs for diabetes related foot issues and how to seek help as required.. We promoted better understanding of when to access emergency care to help to prevent amputations. We have developed new webpages and resources for health care professionals professionals related to periodontitis, sexual dysfunction and have created three Best Practice Guides. Through our substantive engagement with stakeholder organisations, such as Diabetes UK and the Primary Care Diabetes Society we have extended our reach to both healthcare professionals and patients.

Consultation with stakeholders

Ideal has regular contact with its key stakeholders, these being people with and at risk of diabetes and the healthcare professionals that provide care for them. The company’s directors are representatives of both. Our advisory group includes senior representatives of Diabetes UK, the Primary Care Diabetes Society, The British Dietetic Association, as well as numerous leading academic and clinical institutions. In shaping each piece of work we undertake, we have engaged with these and other organisations, including the Juvenile Diabetes Research Foundation, Diabetes Wellness and Research Foundation, local patient groups across the UK, NHS England, the International Diabetes Federation, D-Foot International.

Directors' remuneration

The aggregate amount of emoluments paid to or receivable by directors in respect of qualifying services was £18,550.There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
1 March 2024

And signed on behalf of the board by:
Name: John Grumitt
Status: Director